These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Imipenem/cilastatin: the first carbapenem antibiotic. Lyon JA Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385 [TBL] [Abstract][Full Text] [Related]
8. Studies on the degradation of imipenem within serum and a renal kidney fraction. Köller M; Brom J; Schönfeld W; Knöller J; König W Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):330-7. PubMed ID: 3090805 [TBL] [Abstract][Full Text] [Related]
9. Treatment of pneumonia with imipenem/cilastatin. Beasley CR; Humble MW; O'Donnell TV N Z Med J; 1985 Jun; 98(781):494-7. PubMed ID: 3859775 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol]. Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the mammalian beta-lactamase renal dipeptidase (dehydropeptidase-I) by (Z)-2-(acylamino)-3-substituted-propenoic acids. Graham DW; Ashton WT; Barash L; Brown JE; Brown RD; Canning LF; Chen A; Springer JP; Rogers EF J Med Chem; 1987 Jun; 30(6):1074-90. PubMed ID: 3495664 [TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients. Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422 [TBL] [Abstract][Full Text] [Related]
14. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes. Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314 [TBL] [Abstract][Full Text] [Related]
15. Reduction of cyclosporin (CSA) nephrotoxicity by imipenem/cilastatin after kidney transplantation in rats. Hammer C; Thies JC; Mraz W; Mihatsch M Transplant Proc; 1989 Feb; 21(1 Pt 1):931. PubMed ID: 2650296 [No Abstract] [Full Text] [Related]
16. Potentiation of neurotoxic side effects by coadministration of imipenem to cyclosporine therapy in a kidney transplant recipient--synergism of side effects or drug interaction? Zazgornik J; Schein W; Heimberger K; Shaheen FA; Stockenhuber F Clin Nephrol; 1986 Nov; 26(5):265-6. PubMed ID: 3467883 [No Abstract] [Full Text] [Related]
17. [Efficacy and tolerability of imipenem/cilastatin in infections at various sites]. Grassi C; Baglioni A; Bonsignore G; Catena E; De Rose V; Grignani F; Lotti T; Orlandi O; Panichi G; Pavone Macaluso M G Ital Chemioter; 1986; 33(2-3):143-8. PubMed ID: 3479372 [No Abstract] [Full Text] [Related]
18. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions. Bigley FP; Forsyth RJ; Henley MW Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590 [TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. Calandra GB; Hesney M; Brown KR Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144 [TBL] [Abstract][Full Text] [Related]